Updated efficacy results from the JAVELIN Renal 101 trial: first-line avelumab plus axitinib versus sunitinib in patients with advanced renal cell carcinoma-Reference-Cited by-同舟云学术

Updated efficacy results from the JAVELIN Renal 101 trial: first-line avelumab plus axitinib versus sunitinib in patients with advanced renal cell carcinoma

Published:2020-08 Issue:8 Volume:31 Page:1030-1039
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Choueiri T.K.,Motzer R.J.,Rini B.I.,Haanen J.,Campbell M.T.,Venugopal B.,Kollmannsberger C.,Gravis-Mescam G.,Uemura M.,Lee J.L.,Grimm M.-O.,Gurney H.,Schmidinger M.,Larkin J.,Atkins M.B.,Pal S.K.,Wang J.,Mariani M.,Krishnaswami S.,Cislo P.,Chudnovsky A.,Fowst C.,Huang B.,di Pietro A.,Albiges L.

Funder

Merck KGaA

Pfizer

Publisher

Elsevier BV

Subject

Oncology,Hematology

Reference17 articles.

1. New treatment options for metastatic renal cell carcinoma with prior anti-angiogenesis therapy;Zarrabi;J Hematol Oncol,2017

2. Systemic therapy for metastatic renal-cell carcinoma;Choueiri;N Engl J Med,2017

3. Inlyta (Axitinib) [Prescribing Information],2018

4. Avelumab monotherapy as first-line or second-line treatment in patients with metastatic renal cell carcinoma: phase Ib results from the JAVELIN Solid Tumor trial;Vaishampayan;J Immunother Cancer,2019

5. Avelumab plus axitinib versus sunitinib for advanced renal-cell carcinoma;Motzer;N Engl J Med,2019

Cited by 332 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Discovery of SILA-123 as a Highly Potent FLT3 Inhibitor for the Treatment of Acute Myeloid Leukemia with Various FLT3 Mutations;Journal of Medicinal Chemistry;2024-09-11

2. Can Cytoreductive Nephrectomy Improve Outcomes of Nivolumab Treatment in Patients with Metastatic Clear-Cell Renal Carcinoma?;Current Oncology;2024-09-04

3. Randomized phase 2 dose comparison LITESPARK-013 study of belzutifan in patients with advanced clear cell renal cell carcinoma;Annals of Oncology;2024-09

4. Cabozantinib Plus Nivolumab in Adult Patients with Advanced or Metastatic Renal Cell Carcinoma: A Retrospective, Non-Interventional Study in a Real-World Cohort/GUARDIANS Project;Cancers;2024-08-28

5. The treatment of metastatic renal cell carcinoma;Deutsches Ärzteblatt international;2024-08-23